Integrity CE
2024 Upstate NY Cancer Symposium
Integrity CE
Management of mNSCLC Without Actionable Mutations
FEATURING
Megan Baumgart,
Stephen Liu
- 116 views
- September 3, 2024
- 1
Integrity CE
Management of Stage IV NSCLC With Actionable Mutations
FEATURING
Grace Dy
- 170 views
- September 3, 2024
- 3
Integrity CE
Current Updates in the Management of NDMM
FEATURING
Jens Hillengass,
Saad Usmani
- 81 views
- August 15, 2024
Integrity CE
Treatment Strategies for R/R MM After Frontline Anti-CD38 Therapy
FEATURING
Saad Usmani,
Jens Hillengass
- 208 views
- August 13, 2024
- 2
Integrity CE
How the Experts Treat: Early Stage NSCLC With Curative Intent
FEATURING
Stephen Liu
- 144 views
- August 8, 2024
Integrity CE
Treatment Updates and Management of Non-Hodgkin Lymphomas
FEATURING
Danielle Wallace,
Matthew Cortese
- 98 views
- August 7, 2024
- 1
Integrity CE
2024 Updates on Myeloproliferative Neoplasms, PV, and ET
FEATURING
Ayalew Tefferi
- 270 views
- August 5, 2024
- 3
Integrity CE
Clinical Roundtable: HR+ BC Early Stage & Metastatic Disease Updates
- 222 views
- August 2, 2024
- 1
Integrity CE
Updates in the Treatment and Management of Bladder Cancer
FEATURING
Matthew Galsky,
Brendan Guercio
- 283 views
- August 2, 2024
- 1
Integrity CE
How Recent Data Impacts Colon and Rectal Cancer Treatment Decisions
FEATURING
Daniel Mulkerin,
Sarbajit Mukherjee
- 111 views
- August 2, 2024
- 1
Integrity CE
Implementation of Geriatric Assessment in Community Clinical Practice
FEATURING
Jason Zittel
- 75 views
- August 2, 2024
Integrity CE
Neuroendocrine Tumors: Management and Updates
FEATURING
Renuka Iyer
- 553 views
- August 1, 2024
- 7
Integrity CE
Recent Updates in Upper Gl Cancers
FEATURING
Sarbajit Mukherjee
- 344 views
- August 1, 2024
- 3
Integrity CE
How Recent Data Impacts Pancreatic Cancer Management
FEATURING
Michael Pishvaian
- 469 views
- August 1, 2024
- 4